ABBV

AbbVie Inc. NYSE

Healthcare ·Drug Manufacturers - General ·US · abbvie.com

$206.60

Mkt Cap $366.5B

52w Low $176.57 44.0% of range 52w High $244.81

50d MA $215.24 200d MA $217.73

P/E (TTM) 87.2x

EV/EBITDA 26.7x

P/B —

Debt/Equity -21.1x

ROE -55.5%

P/FCF 22.8x

RSI (14) —

ATR (14) —

Beta 0.36

50d MA $215.24

200d MA $217.73

Avg Volume 7.5M

About

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 29, 2026	BMO	2.59	2.65	+2.3%	197.69	-2.9%	+3.1%	+6.9%	+4.5%	—	—	—	—
Feb 4, 2026	BMO	2.65	2.71	+2.3%	225.66	-7.0%	-3.8%	-2.9%	-1.0%	-1.1%	-1.4%	+2.0%	—
Oct 31, 2025	BMO	1.77	1.86	+5.1%	228.20	-2.3%	-4.5%	-7.1%	-5.4%	-5.0%	-4.0%	-1.4%	—
Jul 31, 2025	BMO	2.88	2.97	+3.1%	189.31	+4.1%	-0.2%	+3.1%	+4.2%	+4.9%	+3.7%	+11.9%	—
Apr 25, 2025	BMO	2.38	2.46	+3.4%	180.37	+3.7%	+3.2%	+6.6%	+7.3%	+8.2%	+7.2%	+3.0%	—
Jan 31, 2025	BMO	2.98	2.16	-27.5%	175.65	+6.6%	+4.7%	+8.2%	+8.1%	+9.2%	+9.9%	+20.4%	—
Oct 30, 2024	BMO	2.92	3.00	+2.7%	189.45	+1.1%	+6.4%	+7.6%	+7.4%	+5.8%	+6.5%	-3.4%	—
Jul 25, 2024	BMO	2.57	2.65	+3.1%	176.21	+0.4%	+3.4%	+5.1%	+3.3%	+6.0%	+5.2%	+12.0%	—
Apr 26, 2024	BMO	2.26	2.31	+2.2%	167.29	-0.1%	-4.6%	-3.4%	-2.8%	-3.3%	-3.9%	-7.1%	—
Feb 2, 2024	BMO	2.76	2.79	+1.1%	167.59	+1.1%	+0.6%	+2.2%	+3.4%	+4.4%	+4.3%	+5.6%	—
Oct 27, 2023	BMO	2.86	2.95	+3.1%	145.20	-4.4%	-4.3%	-2.3%	-2.8%	-1.9%	-1.3%	-4.2%	—
Jul 27, 2023	BMO	2.79	2.91	+4.3%	141.90	+1.8%	+4.9%	+6.3%	+5.4%	+4.7%	+5.3%	+3.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Guggenheim	Maintains	Buy → Buy	—	$211.32	$211.00	-0.2%	-2.2%	—	—	—	—
Apr 30	BofA Securities	Upgrade	Neutral → Buy	$234	$203.89	$209.00	+2.5%	+3.6%	+1.3%	—	—	—
Apr 30	Morgan Stanley	Maintains	Overweight → Overweight	—	$203.89	$209.00	+2.5%	+3.6%	+1.3%	—	—	—
Apr 30	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$203.89	$209.00	+2.5%	+3.6%	+1.3%	—	—	—
Apr 30	Canaccord Genuity	Maintains	Buy → Buy	—	$203.89	$209.00	+2.5%	+3.6%	+1.3%	—	—	—
Apr 23	Piper Sandler	Maintains	Overweight → Overweight	—	$200.50	$201.05	+0.3%	+0.2%	-0.9%	-1.6%	-1.4%	+1.7%
Apr 21	Canaccord Genuity	Initiates	Buy	$262	$203.71	$204.01	+0.1%	+0.7%	-1.6%	-1.4%	-2.5%	-3.1%
Apr 10	Guggenheim	Maintains	Buy → Buy	—	$212.40	$213.55	+0.5%	-2.1%	-2.8%	-1.0%	-1.9%	-1.6%
Apr 8	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$206.37	$206.26	-0.1%	+2.5%	+2.9%	+0.8%	+0.0%	+1.9%
Feb 18	Piper Sandler	Maintains	Overweight → Overweight	—	$232.86	$234.00	+0.5%	-1.8%	-3.7%	-3.5%	-1.5%	-1.9%
Feb 17	Freedom Broker	Maintains	Buy → Buy	—	$231.50	$232.66	+0.5%	+0.6%	-1.2%	-3.1%	-2.9%	-0.9%
Feb 5	Morgan Stanley	Maintains	Overweight → Overweight	—	$217.11	$216.90	-0.1%	+0.9%	+2.9%	+2.8%	+2.4%	+1.7%
Feb 5	Evercore ISI	Maintains	Outperform → Outperform	—	$217.11	$216.90	-0.1%	+0.9%	+2.9%	+2.8%	+2.4%	+1.7%
Feb 5	UBS	Maintains	Neutral → Neutral	—	$217.11	$216.90	-0.1%	+0.9%	+2.9%	+2.8%	+2.4%	+1.7%
Jan 27	Citigroup	Maintains	Neutral → Neutral	—	$220.77	$220.88	+0.0%	+1.4%	-1.0%	-0.2%	+1.0%	+2.2%
Jan 8	Wolfe Research	Downgrade	Outperform → Peer Perform	—	$233.42	$231.13	-1.0%	-4.0%	-5.7%	-5.7%	-5.4%	-4.9%
Dec 12	Morgan Stanley	Maintains	Overweight → Overweight	—	$223.98	$223.69	-0.1%	-0.3%	+1.5%	-0.1%	+0.1%	-0.5%
Dec 10	HSBC	Upgrade	Hold → Buy	—	$222.99	$225.00	+0.9%	+1.0%	+0.4%	+0.1%	+2.0%	+0.3%
Nov 12	Freedom Broker	Maintains	Buy → Buy	—	$225.17	$225.40	+0.1%	+3.6%	+3.2%	+3.2%	+3.9%	+3.9%
Nov 7	UBS	Maintains	Neutral → Neutral	—	$219.04	$219.31	+0.1%	+0.1%	-0.2%	+2.8%	+6.5%	+6.0%
Nov 5	Piper Sandler	Maintains	Overweight → Overweight	—	$215.89	$215.74	-0.1%	+0.4%	+1.5%	+1.5%	+1.3%	+4.3%
Nov 3	JP Morgan	Maintains	Overweight → Overweight	—	$218.04	$216.68	-0.6%	-2.8%	-1.0%	-0.6%	+0.5%	+0.5%
Nov 3	Citigroup	Maintains	Neutral → Neutral	—	$218.04	$216.68	-0.6%	-2.8%	-1.0%	-0.6%	+0.5%	+0.5%
Oct 20	Guggenheim	Maintains	Buy → Buy	—	$229.57	$231.00	+0.6%	+1.1%	+0.8%	-0.4%	-0.6%	-0.7%
Oct 17	Raymond James	Maintains	Outperform → Outperform	—	$226.87	$227.52	+0.3%	+1.2%	+2.3%	+2.0%	+0.8%	+0.6%
Oct 10	Piper Sandler	Maintains	Overweight → Overweight	—	$230.69	$231.51	+0.4%	-0.1%	-0.2%	-0.7%	-1.9%	-1.7%
Oct 9	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$231.24	$233.27	+0.9%	-0.2%	-0.3%	-0.4%	-0.9%	-2.2%
Oct 3	BofA Securities	Maintains	Neutral → Neutral	—	$236.56	$236.90	+0.1%	-1.1%	-2.7%	-1.6%	-2.2%	-2.5%
Oct 1	HSBC	Downgrade	Buy → Hold	—	$231.54	$233.64	+0.9%	+5.5%	+2.2%	+1.0%	-0.6%	+0.6%
Sep 22	Evercore ISI	Maintains	Outperform → Outperform	—	$222.47	$222.46	-0.0%	+0.1%	+0.1%	-1.1%	-1.8%	-0.8%
Sep 17	Berenberg	Upgrade	Hold → Buy	—	$216.26	$219.10	+1.3%	+2.1%	+2.6%	+2.9%	+2.9%	+2.9%
Sep 16	JP Morgan	Maintains	Overweight → Overweight	—	$217.61	$218.33	+0.3%	-0.6%	+1.5%	+2.0%	+2.2%	+2.3%
Sep 15	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$218.34	$219.60	+0.6%	-0.3%	-1.0%	+1.1%	+1.7%	+1.9%
Sep 12	Wells Fargo	Maintains	Overweight → Overweight	—	$220.22	$219.12	-0.5%	-0.9%	-1.2%	-1.8%	+0.3%	+0.8%
Sep 12	BMO Capital	Maintains	Outperform → Outperform	—	$220.22	$219.12	-0.5%	-0.9%	-1.2%	-1.8%	+0.3%	+0.8%
Aug 13	Cantor Fitzgerald	Maintains	Overweight → Overweight	—	$198.64	$199.76	+0.6%	+1.4%	+3.0%	+4.1%	+4.0%	+3.8%
Aug 1	Raymond James	Maintains	Outperform → Outperform	—	$189.02	$189.92	+0.5%	+3.3%	+4.3%	+5.0%	+3.9%	+5.2%
Aug 1	Guggenheim	Maintains	Buy → Buy	—	$189.02	$189.92	+0.5%	+3.3%	+4.3%	+5.0%	+3.9%	+5.2%
Aug 1	Morgan Stanley	Maintains	Overweight → Overweight	—	$189.02	$189.92	+0.5%	+3.3%	+4.3%	+5.0%	+3.9%	+5.2%
Aug 1	Evercore ISI	Maintains	Outperform → Outperform	—	$189.02	$189.92	+0.5%	+3.3%	+4.3%	+5.0%	+3.9%	+5.2%
May 14	Citigroup	Downgrade	Buy → Neutral	—	$188.00	$186.52	-0.8%	-5.6%	-3.4%	-2.1%	-1.2%	-1.7%
Apr 29	Guggenheim	Maintains	Buy → Buy	—	$192.34	$192.59	+0.1%	+0.6%	+1.4%	+0.5%	+3.2%	+1.9%
Apr 28	BofA Securities	Maintains	Neutral → Neutral	—	$186.06	$188.00	+1.0%	+3.4%	+4.0%	+4.9%	+3.9%	+6.7%
Apr 28	Morgan Stanley	Maintains	Overweight → Overweight	—	$186.06	$188.00	+1.0%	+3.4%	+4.0%	+4.9%	+3.9%	+6.7%
Apr 28	Evercore ISI	Maintains	Outperform → Outperform	—	$186.06	$188.00	+1.0%	+3.4%	+4.0%	+4.9%	+3.9%	+6.7%
Apr 28	Raymond James	Maintains	Outperform → Outperform	—	$186.06	$188.00	+1.0%	+3.4%	+4.0%	+4.9%	+3.9%	+6.7%
Apr 21	BofA Securities	Maintains	Neutral → Neutral	—	$172.99	$173.47	+0.3%	-1.6%	+0.5%	+2.3%	+4.3%	+7.6%
Apr 17	Guggenheim	Maintains	Buy → Buy	—	$171.68	$172.57	+0.5%	+0.8%	-0.9%	+1.2%	+3.1%	+5.1%
Apr 11	Citigroup	Maintains	Buy → Buy	—	$174.20	$173.81	-0.2%	+0.5%	+2.8%	+1.5%	-1.4%	-0.7%
Apr 9	Morgan Stanley	Maintains	Overweight → Overweight	—	$175.67	$168.30	-4.2%	+2.4%	-0.8%	-0.4%	+2.0%	+0.6%